Purchase and sale price, average cost per time, use of base drug Comprehensive report of national hospital data

Medical network, May 9 -- on May 7, the official website of the national health and Health Commission issued the notice of the general office of the national health and Health Commission on printing and distributing the national hospital data reporting management plan (for Trial Implementation) and the notice of the general office of the national health and Health Commission on printing and distributing the national hospital reporting data statistical analysis indicator set (for Trial Implementation) (hereinafter referred to as the notice), aiming to strengthen and standardize the National Hospital Data submission management, improve the analysis and application quality of data submitted by medical institutions, and establish standardized analysis index system of data submitted by hospitals As we all know, medical data is of great practical significance to the compliance supervision of medical service behavior Under the background of medical insurance cost control, clinical pathway, rational drug use and other requirements, relying on information technology, to build a medical service behavior supervision system, through hospital data analysis and support, will undoubtedly change the efficiency of medical services, restrict the behavior of diagnosis and treatment drug use, and bring greater pressure on the increasingly fierce competition in the hospital market As early as 2015, the guideline of the general office of the State Council on the pilot comprehensive reform of urban public hospitals was issued by the national health and Family Planning Commission Guo Ban Fa [2015] No 38 proposed to give full play to the regulatory guidance and supervision of various medical insurance on medical service behaviors and expenses, effectively control medical costs, and gradually extend the supervision of medical insurance on medical institutions to the supervision of medical service behaviors of medical personnel Deepening medicine by the State Council Some opinions of the leading group of health system reform on further promoting the experience of deepening the reform of medical and health system further clearly put forward relevant policies to regulate the diagnosis and treatment behavior, and carry out the whole process monitoring and intelligent audit on the outpatient and inpatient diagnosis and treatment behavior and expenses of all medical institutions by means of information technology, so as to achieve pre reminding, in-process control and post audit According to the latest notice, the operational business level of medical institutions should include comprehensive reporting of drugs Purchase transaction price, summarize and submit "drug price report data sheet", and clearly report in accordance with the information such as drug code, common name, dosage form, specification, conversion coefficient, purchase price, purchase quantity, sales price, sales quantity, manufacturer name, etc of the centralized purchase platform for statistical year, month and upgraded drugs In addition, the notice also puts forward requirements for statistical analysis indicators of reported data, and detailed calculation rules around clinical path management, key disease management, single disease management, rational drug use, outpatient and emergency inpatient medical expenses, outpatient and emergency inpatient medical security, etc Taking the clinical pathway management as an example, the detailed indicators include the number of diseases, patients, patients and departments in the clinical pathway; the sub average drug cost is divided into Chinese medicine, western medicine, Chinese patent medicine, change rate, cost trend and other sub items Industry insiders pointed out that data analysis and medical service behavior supervision have complementary relationship In medical behavior supervision, the process supervision of implementing medical technical specifications is not only the basis, but also the means "Doctor's order is the information source of various medical behaviors Only when the doctor's order complies with the regulatory requirements, can the patients enjoy reasonable and compliant medical services Only by decomposing the data assessment level by level and implementing the indicators to departments or doctors can we achieve the goal of rational drug use " In January of this year, the general office of the State Council printed and distributed the report on strengthening three-level public hospitals Opinions on performance appraisal work, promote the three-level public hospitals to change from scale expansion type to quality benefit type in development mode, from extensive administrative management to all-round performance management in management mode, and carry out index appraisal around medical quality, operation efficiency, sustainable development, satisfaction evaluation and other aspects The top-level policy continued to be promoted, the national health and Health Commission and the National Health Insurance Bureau took the initiative, and several provinces and cities successively issued notices to put forward serious monitoring policies around rational drug use and medical insurance cost control, so as to improve the standardization level of clinical treatment drugs: ● Tianjin has formulated three systems: regular evaluation system for the use of abnormal varieties in medical institutions, quantitative and hierarchical management system for the rational use of drugs in medical institutions, and interview and withdrawal system for the use of abnormal varieties Targeted management is carried out for the auxiliary, nutritional and high priced drugs in clinical diagnosis and treatment, and the drug use behavior of medical institutions is strictly standardized   ● Fujian Medical Insurance Bureau issued the notice of Fujian Medical Insurance Bureau on strengthening the management of drugs under the key monitoring of medical insurance, which will deliver drugs with an average monthly delivery amount of more than 5 million yuan, and drugs with an average monthly delivery amount of more than 2 million yuan and an increase of more than 30% on a month-on-month basis, which are not necessary for disease treatment, with insufficient evidence of clinical efficacy and without authoritative disease diagnosis The drugs recommended by the therapeutic guidelines or not included in the clinical pathway form and without the advantages of pharmacoeconomics shall be monitored ● Beijing Medical Insurance Bureau will explore the establishment of point assessment and ranking system for designated medical institutions in 2019, and establish a comprehensive evaluation system and scoring system for violations of medical institutions, such as failure to strictly implement the real name system for medical treatment, drug exchange, arbitrary charges, multiple charges, repeated charges, fictitious diagnosis and treatment, etc., and the scoring will be linked to the cost of medical institutions In addition, the crackdown on fraud and deception has also hit hard In November last year, CCTV's "focus interview" column exposed the fraud of two designated medical institutions in Shenyang Subsequently, the national health and Health Commission and the National Health Insurance Bureau set up a special working group to crack down on the organized malicious fraud of medical insurance funds, and effectively ensure the safe operation of medical insurance funds   Jiao Yahui, deputy director of the medical administration of the National Health Commission, once said on several occasions that quality control must be carried out by means of information technology, and clinical diagnosis and treatment cases should be uploaded to the national quality control database These clinical diagnosis and treatment behaviors should be strictly supervised by means of information technology, and a mode of continuous improvement should be formed through regular feedback and evaluation mechanism to guide the rational use of drugs Use to squeeze out the "water" in clinical drugs Appendix > > > national hospital data reporting management plan - operation business, national hospital reporting data statistical analysis indicator set (Trial)